Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case report.
Patti F, Leone C, Zappia M
BMC Neurol. 2015; 15:252. Epub 2015 Dec 07. PMID: 26643473.Abstract